Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Nashville, Tennessee 37232


Purpose:

This placebo-controlled study investigates acetyl-L-carnitine in the treatment of septic shock requiring vasopressors.


Study summary:

This is a cross-over study which infuses ALC for 12 out of 18 hours (and placebo the other 6). Patients must have vasopressor-dependent septic shock and be free from renal failure, hepatic failure, and seizures to be eligible.


Criteria:

Inclusion Criteria: - documented or presumed infection - shock requiring vasopressors Exclusion Criteria: - dialysis - hepatic failure - seizures


NCT ID:

NCT00592488


Primary Contact:

Principal Investigator
Todd W. Rice, MD, MSc
Vanderbilt University


Backup Contact:

N/A


Location Contact:

Nashville, Tennessee 37232
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.